Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Memorial Sloan Kettering Cancer Center
Sponsor:
Collaborators:
University of Southern California
Rockefeller University
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01494324
First received: December 13, 2011
Last updated: November 14, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2017
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)